Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
fda
7
×
life sciences
7
×
national blog main
san francisco blog main
national
national top stories
new york blog main
new york top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer drugs
deals
eli lilly
nonalcoholic steatohepatitis
president trump
abbvie
acute myeloid leukemia
What
biotech
7
×
roundup
days
drug
ipo
new
research
annual
attention
bio
cancer
companies
news
raised
therapeutics
week
according
ahead
akcea
alzheimer’s
ambien
american
arrival
asco
assessed
attendees
august
black
busy
camp’s
cases
cash
centers
chicago
cigarettes
city
clinic
clinical
combinations
communities
Language
unset
Current search:
fda
×
biotech
×
" life sciences "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More